|
||||
 |
||||
Dockets
Management
|
||||
|
Food and Drug Administration Dermatologic and Ophthalmic Drugs Advisory Committee
May 29, 2008
FDA
Disclaimer
Portions of this document have been determined to be exempt
from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. §
552).
FDA Briefing Material (pdf)
Sirion
Therapeutics, Inc.
Disclaimer
The statements contained in this document(s) are those of
the product's sponsor, not FDA, and FDA does not necessarily agree with the
sponsor's statements. FDA has not made a final determination about the safety
or effectiveness of the product described in this document.
Briefing Material (pdf)
Page last updated
May 27, 2008
kk |
